3PEAT Corporate AI Training verdict
3PEAT is the clearest option for MAS-regulated Singapore SMEs that want IBF-subsidised AI training delivered on their own Microsoft 365 Copilot, Claude, or Grok stack. The programme is narrow by design: two tracks and one two-day course, with no self-paced or asynchronous option, which rules it out for distributed teams or organisations outside Singapore and Australia. If your team is not MAS-regulated and you need something scalable beyond a cohort of 8 to 10, look elsewhere.
Strengths
IBF subsidy handling is built into the engagement: 3PEAT manages the funding paperwork for MAS-regulated participants, reducing the net cost of the two-day course from S$1,500 to S$450 per person.
Training runs on the client's own licensed tools (Microsoft 365 Copilot, Claude for Business, Grok), so participants leave with prompts and agents that function in their actual work environment, not a demo sandbox.
Weaknesses
Hard minimum cohort floors (10 for half-day tracks, 8 for the two-day course) make this unusable for small teams or organisations that want to pilot with a handful of staff before committing.
No self-paced, asynchronous, or on-demand option exists: every programme requires scheduling a live cohort, which adds lead time and coordination overhead that a software-based training product does not.
Read full 3PEAT Corporate AI Training review →AlphaVue verdict
AlphaVue suits individual investors who want structured, evidence-backed stock research and automated monitoring without manual tracking. It falls short if you need charting or community features. TradingView remains stronger there. Skip it if you rely on technical charting or social trading.
Strengths
Delivers structured BUY/HOLD/SELL verdicts with confidence scores, risk levels, and full evidence trails.
Includes bull-vs-bear debate and multi-agent stress-testing for balanced analysis.
Weaknesses
Lacks advanced charting, technical indicators, or social trading features that platforms like TradingView offer.
Free plan limits to 15 analyses/month and no email alerts, which may be too restrictive for active users.
Read full AlphaVue review →